The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis.


Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
05 2019
Historique:
received: 08 09 2018
revised: 11 10 2018
accepted: 06 11 2018
pubmed: 19 11 2018
medline: 23 2 2020
entrez: 19 11 2018
Statut: ppublish

Résumé

Relapsing polychondritis is a rare, multi-systemic and inflammatory condition of unknown origin. We currently lack a core set of measures to assess and follow damage in patients suffering from this condition. Our primary aim was to derive a disease-specific damage measuring tool for relapsing polychondritis, the Relapsing Polychondritis Damage Index (RPDAM). We performed an international 4-round multicenter Delphi study during which experts were asked to rate the relevance of potential damage items for relapsing polychondritis (141 items were obtained from a literature review and 12 from expert suggestion), using a Likert Scale. The selection of items for each subsequent round was based on the median rating of each item. Twenty-four experts from 11 nationalities participated in round 1 and 22 in rounds 2, 3 and 4. From the initial 153 potential damage items, 44 items were selected during round 1, 30 items during round 2 and 16 during round 3. During round 4, we refined the index to a total of 17 items referring to ear nose and throat, eye, respiratory, cardiovascular and hematological systems as well as to treatment-related specific damage items. We have developed by international consensus a scoring system to assess damage in patients with relapsing polychondritis. Following its validation, the RPDAM may contribute to improve the care of patients suffering from this rare condition as well as to standardize data collection for future clinical trials.

Identifiants

pubmed: 30448476
pii: S1297-319X(18)30300-2
doi: 10.1016/j.jbspin.2018.11.001
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-368

Informations de copyright

Copyright © 2018. Published by Elsevier Masson SAS.

Auteurs

Philippe Mertz (P)

Service de rhumatologie, centre de référence des maladies autoimmunes systemiques rares Est Sud-Ouest (RESO), hôpital de Hautepierre, 1, avenue Molière BP 83049, 67098 Strasbourg cedex, France; Inserm UMR-S1109, 67098 Strasbourg cedex, France.

Alexandre Belot (A)

Department of paediatric nephrology, rheumatology, dermatology, hôpital Femme-Mère Enfant, Bron, France.

Ricard Cervera (R)

Department of autoimmune diseases, institut clinic de medicina i dermatología, hospital clínic, Barcelona, Spain.

Tyng Yu Chuah (TY)

Department of rheumatology and immunology, Singapore general hospital, Singapore.

Lorenzo Dagna (L)

Unit of immunology, rheumatology, allergy and rare diseases (UnIRAR), IRCCS San Raffaele scientific institute, Vita-Salute San Raffaele university, 20132 Milan, Italy.

Laura Damian (L)

Rheumatology department, Spitalul clunic Judetean de Urgenta Cluj. Cluj-Napoca, Romania.

Debashish Danda (D)

Department of clinical immunology and rheumatology, Christian medical college, Vellore, India.

David D'cruz (D)

Louise Coote Lupus Unit, Guy's Hospital, London, UK.

Gerard Espinosa (G)

Department of autoimmune diseases, institut clinic de medicina i dermatología, hospital clínic, Barcelona, Spain.

Camille Frances (C)

Dermatology department, hôpital Tenon, Paris, France.

David Jayne (D)

Department of medicine, university of Cambridge, Cambridge, UK.

Kong Kok Ooi (KK)

Division of rheumatology, national university hospital, Singapore city, Singapore; Yong Loo Lin school of medicine, national university, Singapore city, Singapore.

Eugene J Kucharz (EJ)

Department of internal medicine and rheumatology, medical university of Silesia, Katowice, Poland.

Robert Lebovics (R)

Department of otolaryngology, from Mount Sinai St. Luke's and Mount Sinai Roosevelt affiliated with the Icahn school of medicine at Mount Sinai, New York, NY, United States.

Isabelle Marie (I)

Department of internal medicine, CHU de Rouen-Bois Guillaume, Rouen cedex, France.

Guillaume Moulis (G)

Department of internal medicine, CHU de Toulouse, Toulouse, France; UMR 1027 Inserm-university of Toulouse, CIC 1436, CHU de Toulouse, Toulouse, France.

Stanford Peng (S)

Swedish Medical Center, Seattle, Washington, USA.

Aman Sharma (A)

Clinical immunology and rheumatology services, department of internal medicine, postgraduate institute of medical education and research (PGIMER), Chandigarh, 160012, India.

Noboru Suzuki (N)

Institute of medical science and department of immunology and medicine, St. Marianna University school of medicine, Kawasaki, 216-8511, Japan.

Toshio Tanaka (T)

Department of clinical application of biologics, Osaka university graduate school of medicine, Osaka University, Osaka 565-0871, Japan.

Ronald Van Vollenhoven (R)

Department of clinical immunology and rheumatology, academic medical center, Amsterdam, The Netherlands.

Jean Sibilia (J)

Service de rhumatologie, centre de référence des maladies autoimmunes systemiques rares Est Sud-Ouest (RESO), hôpital de Hautepierre, 1, avenue Molière BP 83049, 67098 Strasbourg cedex, France; Inserm UMR-S1109, 67098 Strasbourg cedex, France.

Jacques Eric Gottenberg (JE)

Service de rhumatologie, centre de référence des maladies autoimmunes systemiques rares Est Sud-Ouest (RESO), hôpital de Hautepierre, 1, avenue Molière BP 83049, 67098 Strasbourg cedex, France; Inserm UMR-S1109, 67098 Strasbourg cedex, France.

François Chasset (F)

Dermatology department, hôpital Tenon, Paris, France.

Laurent Arnaud (L)

Service de rhumatologie, centre de référence des maladies autoimmunes systemiques rares Est Sud-Ouest (RESO), hôpital de Hautepierre, 1, avenue Molière BP 83049, 67098 Strasbourg cedex, France; Inserm UMR-S1109, 67098 Strasbourg cedex, France. Electronic address: Laurent.arnaud@chru-strasbourg.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH